FIGURE 4.
Prodrug strategies. (a) Example of a photoactivatable octahedral RhIII complex with an extended diimine ligand. (b) Satraplatin. (c) Example of a photoactivatable trans-azido platinum(IV) prodrug. (d) Ferrocifen. (e) Cobalt-marimastat bioconjugate. (f) RuII arene complexes containing iodo and phenylplazopyridine ligand. (g) RuII arene complexes containing a thiolate ligand. (h) Pt(IV)-estradiol bioconjugate. (i) Ethacraplatin.